(Press-News.org) 26 April 2025, Boston—Healthcare practitioners from around the world received hands-on training for treating patients in cardiogenic shock (CS) during a first-ever simulation lab at today’s Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT) in Boston.
The simulation lab was part of ISHLT’s inaugural Cardiogenic Shock Academy, a day-long session featuring a case-based forum and discussion of hot topics and anticipated developments in the treatment of CS. More than 160 healthcare practitioners from around the world attended the academy, which was designed to address the lack of conclusive research for managing CS.
CS is a life-threatening condition that occurs when the heart is unable to pump enough blood and oxygen through the body. It may be caused by a severe heart attack (50 percent of cases), end-stage heart failure, certain arrhythmias, and viral infections. If not identified or treated quickly, it can lead to organ failure, brain injury, or death.
CS is the number one reason patients end up in the cardiac care unit (CCU). Despite significant medical advances, 40-50 percent of patients in CS remain at risk of dying during their hospitalization.
“Treatment focuses on getting blood flowing properly and protecting organs from damage,” said Manreet Kanwar, MD, Cardiogenic Shock Academy co-chair and director for the Division of Heart Failure, University of Chicago.
Using computer software, a mannequin, and mechanical circulatory support (MCS) devices, the lab simulated various patient scenarios that presented practitioners with decision-making opportunities. The MCS devices involved in the training were extracorporeal membrane oxygenation, or ECMO, and an intravascular microaxial blood pump. These devices support the function of the heart and improve systemic circulation.
“The Simulation Lab provides actionable information to help practitioners improve patient management and outcomes,” Dr. Kanwar said. “Attendees left the academy with practical skills to take home and use at the patient's bedside.”
CS may be caused by a severe heart attack, heart failure, certain arrhythmias, and viral infections not treated quickly; it can lead to organ failure, brain injury, or death.
“This patient population is very high risk, so there have been very few clinical trials,” said Dr. Kanwar. “As a result, there are few guidelines on managing CS patients.”
As an international and multidisciplinary organization, ISHLT was able to bring together key opinion leaders from around the world to discuss and share best practices.
“We designed the Cardiogenic Shock Academy to be clinically relevant and translatable across different regions and medical systems,” she said. “I think there’s enough momentum in the field that with more science, technology, medical therapies, and exchange of information, we will begin to make a dent in the bigger picture.”
Alexander Bernhardt, MD, attending cardiac surgeon at the University Heart and Vascular Center in Hamburg, Germany, co-chaired the Cardiogenic Shock Academy. Jose Gonzalez-Costello, MD, MSc, PhD, Team Leader/Cardiology Representative at Bellvitge Hospital in Barcelona, Spain, hosted the Simulation Lab.
According to the World Heart Federation, deaths from cardiovascular disease were 20.5 million in 2021, surging 60 percent over the past three decades. In the US alone, approximately 805,000 heart attacks occur every year (American Heart Association). Based on those numbers, up to 56,000 patients may experience CS annually in the US alone.
END
About ISHLT
The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support, and innovative therapies via research, education, and advocacy. ISHLT members focus on transplantation and a range of interventions and therapies related to advanced heart and lung disease.
The ISHLT Annual Meeting and Scientific Sessions will be held from 27 to 30 April at the John B. Hynes Veterans Memorial Convention Center in Boston.
Contact:
Jess Burke, Director of Marketing and Communications
+1.312.224.0015
jess.burke@ishlt.org
END
Tokyo, Japan – A scientist from Tokyo Metropolitan University has solved the longstanding problem of a “dissonance” in gravitational waves emitted by a black hole. Using high precision computing and a new theoretical physics framework, it was discovered that it was caused by a resonance between a pair of distinctive “modes” i.e. different ways in which a black hole can “ring.” The phenomenon offers new insights into the nascent field of black hole spectroscopy.
Black holes are astrophysical objects so dense that even light cannot escape their gravitational pull. Despite their awesome presence ...
The less intensively you manage the soil, the better the soil can function. Such as not ploughing as often or using more grass-clover mixtures as cover crops. These are the conclusions from a research team led by the Netherlands Institute of Ecology (NIOO-KNAW). Surprisingly, it applies to both conventional and organic farming. These important insights for making agriculture more sustainable are published in the scientific journal Science today. ‘It offers clear evidence to help farmers manage soils better.’
Growing food more sustainably: what's the best way to do this? It is ...
WOODS HOLE, Mass. -- The Frontiers Planet Prize, the world’s largest science competition to enhance planetary health by fast-tracking innovative research, has announced National Champions from 19 different countries who now advance to the International competition, which will award three winners $1M each to scale up their research.
Suzanne Tank and co-authors from the Arctic Great Rivers Observatory (ArcticGRO), a multinational project founded at the Marine Biological Laboratory (MBL), were recognized for their publication, “Recent trends in the chemistry of major northern rivers signal widespread Arctic change,” published ...
Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the United States are affected, and doctors still don’t know what causes it. To lay the groundwork for better tests, Thomas Jefferson University researchers Phillipe Loher, Eric Londin, PhD, and Isidore Rigoutsos, PhD are taking a computational biology approach to see how ALS affects molecules in the blood.
In a study published in Molecular Neurobiology, the team analyzed blood samples from about 300 people with and without ALS. The research focused on small non-coding ...
As the opioid crisis continues, the number of babies born with neonatal opioid withdrawal syndrome (NOWS) – a condition that affects infants whose mothers used opioids during pregnancy – has risen 5-fold over the past 20 years. According to the Centers for Disease Control (CDC), there are 20,000 infants a year in the United States born with signs of NOWS. These infants often require extended hospital stays and, in some cases, treatment with medications like morphine to relieve withdrawal symptoms.
A new study from Walter Kraft, MD, an internist and clinical pharmacologist at Thomas Jefferson University, ...
Leadership from the University of Tennessee, Knoxville, Volkswagen Group of America and Oak Ridge National Laboratory celebrated more than a decade of collaboration and the fifth anniversary of the Volkswagen Innovation Hub Knoxville on April 24. Since 2011, UT and Volkswagen have partnered on strategic research projects that have accelerated the discovery and commercialization of new technology, including battery performance, materials science, power electronics and mobility ...
PHILADELPHIA – Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000—until recently. Thanks to changes in Medicare Part D introduced by the Inflation Reduction Act (IRA) that took effect in 2025, annual out-of-pocket drug costs for all beneficiaries are now capped at $2,000. However, an overlooked voluntary program that’s part of the IRA could be the key to improving affordability for Medicare patients needing expensive oral cancer drugs, according to a new study from researchers ...
Senescent skin cells, often referred to as zombie cells because they have outlived their usefulness without ever quite dying, have existed in the human body as a seeming paradox, causing inflammation and promoting diseases while also helping the immune system to heal wounds.
New findings may explain why: Not all senescent skin cells are the same.
Researchers from Johns Hopkins University have identified three subtypes of senescent skin cells with distinct shapes, biomarkers, and functions—an advance that could equip scientists with the ability to target and kill the harmful types while leaving the helpful ones intact.
The findings were published today ...
University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research Annual Meeting 2025 in Chicago.
Study finds contrasting effects of protein on head and neck cancer
A small protein called IL-9 has been shown to either contribute to or counteract tumor growth depending on the type of cancer, but its role in head and neck cancer has not been studied.
Abstract lead author Sam Nusbaum and her colleagues found IL-9 levels are increased in patients with head and neck cancer compared to healthy controls.
“High ...
BOSTON, April 25, 2025 – Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer. The results of these studies, along with dozens of others led by Dana-Farber faculty, will be presented at this year’s American Association for Cancer Research (AACR) Annual Meeting held April 25-30, 2025, in Chicago.
The institute’s leading experts and researchers will present findings across a spectrum of diseases, underscoring ...
